Mandate

Vinge advises Fractal Gaming Group AB (publ) in connection with its listing on Nasdaq First North Premier Growth Market

Vinge advises Fractal Gaming Group AB (publ) (“Fractal”) in connection with its listing on Nasdaq First North Premier Growth Market.

The offering circular was published on 2 February 2021 and first day of trading on Nasdaq First North Premier was 11 February 2021. The offer price was set at SEK 41, corresponding to a total value of the total amount of outstanding shares in the company of approximately SEK 1,194 million. The Offering comprised of 13,418,108 existing shares, corresponding to a total value of approximately SEK 550 million provided an overallotment option was exercised in its entirety.

Fractal is a leading company in the premium segment of PC gaming products. The group was founded in 2010 and its products are currently sold in more than 50 markets worldwide. Fractal is a market leader in premium PC cases in several geographic markets, for example in the Nordic region, is top two in Japan, and holds a top-three position globally. The company also has a strong market position within power supply units, cooling products and fans for gaming computers.

Vinge’s team mainly consisted of Johan Winnerblad, Jesper Schönbeck, Rikard Lindahl, Filip Öhrner, William Kåge, Hannah Kajlinger, Anders Sundin Lundberg, Clara Sohlberg and Olivia Belding.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025